# Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality

> **NCT03992443** · PHASE3 · WITHDRAWN · sponsor: **Chiesi Farmaceutici S.p.A.**

## Conditions studied

- Restoration of Function to CVADs

## Interventions

- **DRUG:** CUSA-081

## Key facts

- **NCT ID:** NCT03992443
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-28
- **Primary completion:** 2022-03-18
- **Final completion:** 2022-03-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Chiesi business decision
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03992443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03992443, "Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functionality". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03992443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*